Search

everythinglearnresearchcommunity

for

Search:↓

Exosomes could improve skin and hair treatments but are limited by cost, production difficulty, and need for more research.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

Delta-opioid receptors affect skin cell circadian rhythms, possibly impacting wound healing and cancer.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Honeybees face serious threats from various diseases, but beekeepers use several methods to manage and control them.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

Standardized procedures are crucial for collecting and preparing biological samples to ensure accurate clinical metabolomics results.

Bioassays help find useful compounds in nature for making medicines, supplements, and cosmetics.

Some people experience lasting sexual, psychological, and sleep problems after using finasteride or SSRI antidepressants, possibly due to similar underlying causes.

PCOS may increase the risk of mental health issues like depression and anxiety.

Fermenting Dendrobium officinale with Lactobacillus reuteri CCFM8631 increases its skin care benefits.

Human skin xenografting could improve our understanding of skin development, renewal, and healing.

The circadian clock plays a key role in hair growth and its disruption can affect hair regeneration.

Myo-inositol plus α-lactalbumin works better than myo-inositol alone for improving symptoms of PCOS.

Surgery can be a safe and effective option for infertile women with PCOS who don't respond to medication and want to get pregnant.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

Wearing a hijab changes the common bacteria and fungi on the scalp, possibly affecting skin health.

Root hairs are key for developing cereals that can fertilize themselves with nitrogen.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

Alopecia areata patients have more Propionibacterium acnes and less Staphylococcus epidermidis on their scalps.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

Botulinum toxin may help hair loss by increasing blood flow and reducing harmful factors.

Researchers found certain genes are overactive and others are underactive in men with early balding, which could help create new treatments.

LED therapy is safe and shows potential for treating skin conditions and promoting hair growth, but more research is needed.

Using combined treatments can help manage acne by targeting the bacteria and skin changes that cause it.

Different types of stem cells exist within individual skin layers, and they can adapt to damage, transplantation, or tumor growth. These cells are regulated by their environment and genetic factors. Tumor growth is driven by expanding, genetically altered cells, not long-lived mutant stem cells. There's evidence of cancer stem cells in skin tumors. Other cells, bacteria, and genetic factors help maintain balance and contribute to disease progression. A method for growing mini organs from single cells has been developed.

A certain smell receptor in hair follicles can affect hair growth when activated by a synthetic sandalwood scent.

Adult female acne requires a comprehensive treatment approach, including medical options and lifestyle changes, with attention to psychological well-being.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.